Significant progress has been made toward tuberculosis (TB) elimination in the US, resulting in one of the lowest TB incidence rates in the world.
1 From 2010 to 2019, US TB incidence fell 25% to a rate of 2.7 cases per 100 000 persons, with a larger 44% decline among US-born persons, reaching a rate of 0.9 per 100 000 persons.
2 TB disease arises from the progression of previously acquired
Mycobacterium tuberculosis (Mtb) infection or a recent transmission event, with an estimated 13% of TB among US-born persons attributable to recent transmission from 2018 to 2019.
2,3 TB case-fatality rates remained stable from 2010 to 2019.
2 Despite these achievements in low TB incidence, transmission, and case-fatality rates, substantial racial and ethnic disparities persist in both TB incidence and case-fatality among US-born persons.
3-5